Cyclerion Therapeutics

PriceCyclerion Therapeutics

CYCN

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Historical stock price chart and annual return over the past years

-95%

5 years

% Total

CYCN
-45%

5 years

Annual Return

CYCN